Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-000398
Filing Date
2025-01-02
Accepted
2025-01-02 16:30:07
Documents
14
Period of Report
2024-12-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0226552-8ka1_180life.htm   iXBRL 8-K/A 90390
  Complete submission text file 0001213900-25-000398.txt   319121

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20241227.xsd EX-101.SCH 3787
3 XBRL DEFINITION FILE atnf-20241227_def.xml EX-101.DEF 26629
4 XBRL LABEL FILE atnf-20241227_lab.xml EX-101.LAB 36680
5 XBRL PRESENTATION FILE atnf-20241227_pre.xml EX-101.PRE 25253
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0226552-8ka1_180life_htm.xml XML 6400
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38105 | Film No.: 25502459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)